ArticleBriefings in bioinformatics2025
Federated transfer learning with differential privacy for multi-omics survival analysis.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Radiomic and dosiomic machine learning models for predicting radiation-induced oral mucositis in head and neck cancer: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Pooled it
- Comment on "Privacy-preserving multicenter validation of the RMODscore".Journal of cancer research and clinical oncology · 2026Article
- Integration of artificial intelligence and multi-omics for precision medicine.Functional & integrative genomics · 2026Review
- MoESurv: a zero-sample and transferable survival prediction framework for rare cancers using mixture of experts.Bioinformatics (Oxford, England) · 2026Article
- Foundation models in omics research: a comprehensive survey.Briefings in bioinformatics · 2026Review
- Artificial intelligence integrated multi-omics and multimodal studies promote the efficacy of neoadjuvant chemotherapy in breast cancer: opportunities, challenges, and future perspectives.Breast cancer research : BCR · 2026Review
- A Pragmatic Framework for Federated Learning Risk and Governance in Academic Medical Centers.JMIR AI · 2026Article
- Artificial intelligence for comprehensive DNA methylation analysis: overview, challenges, and future directions.Briefings in bioinformatics · 2025Review
- Artificial intelligence in modern clinical practice (Review).Medicine internationalReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Multi-omics data often suffer from the "big $p$, small $n$" problem where the dimensionality of features is significantly larger than the sample size, making the integration of multi-omics data for survival analysis of a specific cancer particularly challenging. One common strategy is to share multi-omics data from other related cancers across multiple institutions and leverage the abundant data from these cancers to enhance survival predictions for the target cancer. However, due to data privacy and data-sharing regulations, it is challenging to aggregate multi-omics data of related cancers from multiple institutions into a centralized database to learn more accurate and robust models for the target cancer. To address the limitation, we propose a multi-omics survival prediction model with self-attention mechanism (MOSAHit), trained within a federated transfer learning framework with differential privacy. This approach enables the learning of a more robust multi-omics survival prediction model for a local target cancer with limited training data by effectively leveraging multi-omics data of related cancers distributed across multiple institutions while preserving individual privacy. Results from the comprehensive experiments on real-world datasets show that the proposed method effectively alleviates data insufficiency and significantly improves the generalization performance of multi-omics survival prediction model for a target cancer while avoiding the direct sharing of multi-omics data for related cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.